Andrew Miller
2018 - Karuna Therapeutics
In 2018, Andrew Miller earned a total compensation of $575.1K as Chief Operating Officer at Karuna Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $191,870 |
|---|---|
| Option Awards | $112,527 |
| Salary | $262,485 |
| Other | $8,250 |
| Total | $575,132 |
Miller received $262.5K in salary, accounting for 46% of the total pay in 2018.
Miller also received $191.9K in non-equity incentive plan, $112.5K in option awards and $8.3K in other compensation.
Rankings
In 2018, Andrew Miller's compensation ranked 11,425th out of 14,244 executives tracked by ExecPay. In other words, Miller earned more than 19.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,425 out of 14,244 | 20th |
Division Manufacturing | 4,612 out of 5,758 | 20th |
Major group Chemicals And Allied Products | 1,745 out of 2,119 | 18th |
Industry group Drugs | 1,482 out of 1,808 | 18th |
Industry Pharmaceutical Preparations | 1,136 out of 1,382 | 18th |
Source: SEC filing on April 29, 2020.
Miller's colleagues
We found two more compensation records of executives who worked with Andrew Miller at Karuna Therapeutics in 2018.
News
Karuna Therapeutics CEO Steven Paul's 2021 pay jumps 48% to $13M
April 27, 2022
Karuna Therapeutics CEO Steven Paul's 2020 pay slips 11% to $8.9M
April 27, 2021
Karuna Therapeutics CEO Steven Paul's 2019 pay jumps 932% to $10M
April 29, 2020
PTC CEO James Heppelmann's 2018 pay jumps 357% to $50M
January 23, 2019